Avricore Health (AVCRF) FCF Margin (2015 - 2025)
Avricore Health (AVCRF) reported FCF Margin of 1085.75% for Q3 2025, down 115550.0% year-over-year from N/an in Q3 2024, and down 160.35% quarter-over-quarter from 417.03% in Q2 2025.
Avricore Health (AVCRF) FCF Margin (2015 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 11 years of FCF Margin data on file, last reported at 1085.75% in Q3 2025.
- FCF Margin for Q3 2025 came in at 1085.75%, down 115550.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 15.01% (down 6654.0% YoY), and the FY2025 annual result was 131.38%, down 15616.0% from the prior year.
- FCF Margin eased to 1085.75% in Q3 2025 per AVCRF's latest filing, from 417.03% in the prior quarter.
- Over five years, FCF Margin peaked at 109.67% in Q3 2022 and troughed at 6204.37% in Q2 2021.
- A 5-year average of 748.38% and a median of 46.19% in 2024 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2021 and 2022: FCF Margin plunged 315127 bps in 2021, then jumped 606906 bps in 2022.
- A 5-year view of FCF Margin shows it stood at 1359.57% in 2021, then jumped by 85 bps to 202.79% in 2022, then surged by 122 bps to 43.66% in 2023, then surged by 60 bps to 69.75% in 2024, then slumped by 1657 bps to 1085.75% in 2025.
- Business Quant data shows AVCRF's FCF Margin at 1085.75% in Q3 2025, 417.03% in Q2 2025, and 65.95% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3.31% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 7.41% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 18.23% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 22.61% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 10.95% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 2.59% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 11.83% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 23.01% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 12.92% |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,085.75% |
| Jun 30, 2025 | -417.03% |
| Mar 31, 2025 | 65.95% |
| Sep 30, 2024 | 69.75% |
| Jun 30, 2024 | 50.27% |
| Mar 31, 2024 | 42.93% |
| Dec 31, 2023 | 43.66% |
| Sep 30, 2023 | 47.39% |
| Jun 30, 2023 | 58.86% |
| Mar 31, 2023 | 50.26% |
| Dec 31, 2022 | -202.79% |
| Sep 30, 2022 | 109.67% |
| Jun 30, 2022 | -135.31% |
| Mar 31, 2022 | -456.27% |
| Dec 31, 2021 | -1,359.57% |
| Sep 30, 2021 | -356.00% |
| Jun 30, 2021 | -6,204.37% |
| Mar 31, 2021 | -3,792.40% |
| Dec 31, 2020 | -4,362.60% |
| Sep 30, 2020 | -2,231.70% |